CBC

The development of prophylactic vaccines against HIV is of paramount importance in the global efforts to halt the spread of the virus. The Clinical Bioreagent Center (CBC) it's being utilized in the production of clinical-grade vaccine candidates based on the viral envelope protein (EnV). Our goal is to streamline the process development pipeline of a promising biotherapeutic from lead to clinic. The CBC develops tailored analytical tools for a wide array of biological products in a good manufacturing practice environment... Collaborate with clients to develop drugs that are safe and of the utmost quality. Develop tailored analytical tools to streamline the process development pipeline of a promising biotherapeutic from lead to clinic.

Primary location: San Juan